Abbott India Limited share price

Key numbers

Market cap

₹ 57,278 Cr

Current price

₹ 26,955.00

52-week high / low

₹ 30,655 / 25,135

Stock P/E

35.5

Book value

₹ 2,246.8

Dividend yield

1.95%

ROCE

44.9%

ROE

34.5%

Debt to equity

0.04

Sales growth (3 yrs)

9.0%

Profit growth (3 yrs)

17.8%

1-year return

-10.8%

About Abbott India Limited

Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women's health, metabolic, hypothyroidism, central nervous system, vaccines, and multispecialty, including insomnia, vertigo, vitamin D deficiency, pre-term labor, and pain management. It also provides anti-infectives, cardio-diabeto, GI & hepato, hormones, neuro-psychiat, respiratory, hepatic, neuroscience, metabolics, gennext, and consumer care products. The company was formerly known as Knoll Pharmaceuticals Limited and changed its name to Abbott India Limited in July 2002. The company was founded in 1910 and is headquartered in Mumbai, India. Abbott India Limited operates as a subsidiary of Abbott Capital India Limited.

Quarterly results

Consolidated figures in ₹ crores

Peers in Drug Manufacturers - Specialty & Generic

• Sun Pharmaceutical Industries Limited
• Divi's Laboratories Limited
• Torrent Pharmaceuticals Limited
• Zydus Lifesciences Limited
• Cipla Limited
• Laurus Labs Limited
• Mankind Pharma Limited
• Dr. Reddy's Laboratories Limited
• Aurobindo Pharma Limited
• Lupin Limited